Rafferty Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$250K Buy
11,438
+5,730
+100% +$167K ﹤0.01% 1041
2026
Q2
$207K Buy
+5,708
New +$195K ﹤0.01% 1098
2026
Q1
– Sell
-4,785
Closed -$222K – 1080
2025
Q4
$222K Buy
+4,785
New +$200K ﹤0.01% 1075
2024
Q4
– Sell
-6,225
Closed -$241K – 1148
2024
Q3
$241K Sell
6,225
-81
-1% -$2.89K ﹤0.01% 1070
2024
Q2
$203K Buy
+6,306
New +$219K ﹤0.01% 1139

Other funds holding COLL

Rafferty Asset Management's COLL Position: Q3 2026 in Review

Rafferty Asset Management increased its Collegium Pharmaceutical (COLL) stake by 100% in Q3 2026, buying an estimated $167K and bringing the position to 11,438 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #1041.

Rafferty Asset Management first reported a position in COLL in Q2 2024 and has held it in 5 quarters since. 240 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • Rafferty Asset Management held 11,438 shares of Collegium Pharmaceutical worth $250K as of Q3 2026.
  • Rafferty Asset Management bought 5,730 Collegium Pharmaceutical shares in Q3 2026, an estimated $167K.
  • Collegium Pharmaceutical made up ﹤0.01% of Rafferty Asset Management's portfolio in Q3 2026, its #1041 holding.
  • Rafferty Asset Management first reported a position in Collegium Pharmaceutical in Q2 2024 and has held it in 5 quarters since.
  • 240 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Rafferty Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.